Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder
Pharma Voice
Fri, 07/19/24 - 11:39 am
Kyverna Therapeutics
CAR-T
stiff person syndrome
autoimmune disease
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer
Fierce Pharma
Mon, 07/15/24 - 11:20 pm
CAR-T
Legend Biotech
M&A
Ones to watch - five upcoming companies on the CAR-T scene
Biopharma Reporter
Mon, 07/8/24 - 11:46 am
CAR-T
Cargo Therapeutics
Capstan Therapeutics
Kyverna Therapeutics
Ucello Bio
Verismo Therapeutics
J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma
Fierce Pharma
Tue, 07/2/24 - 11:22 am
JNJ
Legend Biotech
CAR-T
Carvykti
Multiple Myeloma
clinical trials
Lyell Reports Patient Death in Early-Stage CAR T Trial, Shows Otherwise Strong Response Rate
BioSpace
Wed, 06/26/24 - 10:07 am
Lyell Immunopharma
clinical trials
CAR-T
LYL797
patient deaths
Secondary Cancer Risk Is Low After CAR-T Cell Treatment: Stanford Study
BioSpace
Thu, 06/13/24 - 11:21 am
cancer
CAR-T
ASCO24 preview: A look at some of the cancer meeting’s hottest abstracts
BioSpace
Fri, 05/31/24 - 11:03 am
ASCO 2024
Merus
JNJ
CAR-T
Legend Biotech
Pfizer
Genmab
Nanobiotix
ASCO: AffyImmune claims a first with CAR-T for solid tumours
Pharmaphorum
Fri, 05/24/24 - 11:02 am
ASCO 2024
AffyImmune Therapeutics
solid tumors
CAR-T
Galapagos Partners with Blood Centers of America to Decentralize CAR-T Production
BioSpace
Thu, 05/16/24 - 11:28 am
Galapagos
Blood Centers of America
CAR-T
clinical trials
AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist
BioSpace
Mon, 05/6/24 - 11:41 am
AstraZeneca
Cellectis
CAR-T
oncology
allogeneic cells
Allogene’s CAR T clinical trial advances with CIRM grant
Clinical Trials Arena
Mon, 04/29/24 - 11:07 am
Allogene Therapeutics
funding
CAR-T
ALLO-316
renal cell carcinoma
FDA mandates label updates on CAR-T cancer therapies
Reuters
Thu, 04/18/24 - 10:34 pm
CAR-T
FDA
warning
cancer
Gilead Sciences
Bristol Myers Squibb
2seventybio
Brazil’s plan for low-cost CAR-Ts
Stat
Wed, 03/27/24 - 10:49 am
Brazil
CAR-T
Becoming ‘biologic-like’: CAR-T makers on quest to scale drugs’ production
Medical Marketing and Media
Mon, 03/18/24 - 05:13 pm
CAR-T
FDA
drug development
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
JNJ
Legend Biotech
CAR-T
FDA
Carvykti
Abecma
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BioSpace
Fri, 03/15/24 - 11:32 am
Bristol Myers Squibb
CAR-T
CLL
Breyanzi
FDA
JNJ
Carvykti
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year
Fierce Biotech
Fri, 02/23/24 - 10:32 am
Galapagos
layoffs
lupus
CAR-T
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
Stat
Wed, 02/21/24 - 10:47 pm
CAR-T
New England Journal of Medicine
autoimmune disease
FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma
Medical Marketing and Media
Fri, 02/16/24 - 11:42 am
CAR-T
FDA
Peter Marks
CBER
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »